Why the study?
Does nesiritide infusion improve clinical symptoms and mortality in patients with acute decompensated congestive heart failure?
Population
Patients with acute decompensated congestive heart failure (CHF)
Design
Review
Authors
Loading...
Nesiritide effects in acute decompensated HF remain hypothesis-generating; randomized trials needed before clinical adoption.
Does nesiritide infusion improve clinical symptoms and mortality in patients with acute decompensated congestive heart failure?
Nesiritide infusion in acute decompensated heart failure provides beneficial hemodynamic, neurohormonal, and renal effects, leading to improved symptoms and mortality.
Andrew J. Burger (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: